On Invalid Date, Boston Scientific (NYSE: BSX) reported Q4 2023 earnings per share (EPS) of $0.34, up 277.78% year over year. Total Boston Scientific earnings for the quarter were $505.00 million. In the same quarter last year, Boston Scientific's earnings per share (EPS) was $0.09.
As of Q2 2024, Boston Scientific's earnings has grown 140% year over year. This is 51.81 percentage points higher than the US Medical Devices industry earnings growth rate of 88.19%. Boston Scientific's earnings in the past year totalled $1.57 billion.
What is BSX's earnings date?
Boston Scientific's earnings date is Invalid Date. Add BSX to your watchlist to be reminded of BSX's next earnings announcement.
What was BSX's revenue last quarter?
On Invalid Date, Boston Scientific (NYSE: BSX) reported Q4 2023 revenue of $3.73 billion up 14.9% year over year. In the same quarter last year, Boston Scientific's revenue was $3.24 billion.
What was BSX's revenue growth in the past year?
As of Q2 2024, Boston Scientific's revenue has grown 12.29% year over year. This is 3.03 percentage points higher than the US Medical Devices industry revenue growth rate of 9.25%. Boston Scientific's revenue in the past year totalled $14.24 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.